par Bonneterre, J;Chevalier, B;Focan, Christian;Mauriac, L;Piccart-Gebhart, Martine
Référence Annals of oncology, 12, 12, page (1683-1691)
Publication Publié, 2001-12
Référence Annals of oncology, 12, 12, page (1683-1691)
Publication Publié, 2001-12
Article révisé par les pairs
Titre: |
|
Auteur: | Bonneterre, J; Chevalier, B; Focan, Christian; Mauriac, L; Piccart-Gebhart, Martine |
Informations sur la publication: | Annals of oncology, 12, 12, page (1683-1691) |
Statut de publication: | Publié, 2001-12 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Administration, Oral |
Adult | |
Aged | |
Antineoplastic Agents, Phytogenic -- administration & dosage | |
Antineoplastic Agents, Phytogenic -- pharmacokinetics | |
Area Under Curve | |
Breast Neoplasms -- drug therapy | |
Breast Neoplasms -- metabolism | |
Dose-Response Relationship, Drug | |
Female | |
Follow-Up Studies | |
Humans | |
Intestinal Absorption | |
Maximum Tolerated Dose | |
Middle Aged | |
Neoplasm Staging | |
Neutropenia -- chemically induced | |
Safety | |
Treatment Outcome | |
Vinblastine -- administration & dosage | |
Vinblastine -- analogs & derivatives | |
Vinblastine -- pharmacokinetics | |
Note générale: | Clinical Trial |
Clinical Trial, Phase I | |
Journal Article | |
Langue: | Anglais |
Identificateurs: | urn:issn:0923-7534 |
info:doi/10.1023/A:1013529731138 | |
info:scp/0035702333 | |
info:pmid/11843245 |